The assay can also detect and sensitively measure SMN protein in mouse tissues, a capability that has been used to characterize SMN protein expression during development and that can be used to accelerate preclinical development of SMA therapeutics. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.